Science 37 Hldgs Inc (SNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNCE | AZN | AMGN | GILD | VRTX |
| Company | Science 37 Hldgs Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 5.74 | 94.14 | 327.42 | 122.59 | 460.22 |
| High | 5.75 | 94.37 | 327.75 | 123.81 | 462.42 |
| Low | 5.73 | 92.78 | 319.79 | 120.22 | 452.91 |
| Latest | 5.75 | 94.28 | 322.43 | 121.81 | 454.05 |
| Change | +0.02 | +0.65 | -3.11 | -0.79 | -6.54 |
| % Change | +0.35% | +0.69% | -0.96% | -0.64% | -1.42% |
| Volume | 49,100 | 6,253,687 | 1,143,286 | 2,820,693 | 682,427 |
| 20-Day Average Volume | 42,085 | 5,033,824 | 2,718,140 | 6,255,959 | 1,312,676 |
| Previous Close | 5.73 | 93.63 | 325.54 | 122.60 | 460.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.72 | 92.48 | 328.47 | 122.40 | 458.92 |
| 20-Day Raw Stochastic | 100.00% | 59.96% | 15.94% | 47.06% | 26.20% |
| 20-Day Relative Strength | 54.34 | 58.57 | 47.65 | 49.33 | 52.25 |
| Weighted Alpha | -4.20 | +42.98 | +17.88 | +27.75 | +8.65 |
| Today's Opinion | 8% Sell | 100% Buy | 48% Buy | 40% Buy | 64% Buy |
| Previous Opinion | 16% Sell | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 24% Sell | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.35% since 03/04/24 | -1.31% since 01/06/26 | -2.42% since 01/06/26 | +0.39% since 01/06/26 | -2.91% since 01/06/26 |
| Low | 5.72 on 03/05/24 | 92.78 on 01/13/26 | 319.98 on 01/13/26 | 119.33 on 01/09/26 | 452.91 on 01/13/26 |
| High | 5.75 on 03/11/24 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 125.11 on 01/08/26 | 487.52 on 01/07/26 |
| 1-Month | |||||
| %Chg | +1.23% since 02/09/24 | +4.32% since 12/12/25 | +1.39% since 12/12/25 | +1.19% since 12/12/25 | +0.60% since 12/12/25 |
| Low | 5.68 on 02/21/24 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 443.12 on 01/05/26 |
| High | 5.75 on 03/11/24 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +32.49% since 12/11/23 | +10.89% since 10/13/25 | +10.18% since 10/13/25 | +3.07% since 10/13/25 | +11.63% since 10/13/25 |
| Low | 3.73 on 12/21/23 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 7.39 on 12/26/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +7.28% since 09/11/23 | +31.75% since 07/11/25 | +9.11% since 07/11/25 | +11.12% since 07/11/25 | -3.01% since 07/11/25 |
| Low | 3.73 on 12/21/23 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 8.80 on 10/04/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,327 | 290,388,928 | 175,297,120 | 152,107,376 | 116,860,432 |
| Shares Outstanding, K | 5,970 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 70,150,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -50,990,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 14,890,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -13,920,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.55 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.00 on 11/07/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/18/24 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.71 | 14.91 | 14.79 | 30.30 |